Potassium-competitive acid blockers versus proton pump inhibitors: redefining the standards of care in reflux esophagitis
Abstract
Introduction The introduction of antisecretory drugs, such as H2-receptor antagonists (H2RAs) and proton pump inhibitors (PPIs) in clinical practice, has transformed the management of acid-related diseases. This advancement has virtually eliminated the need for elective surgery for peptic ulcer disease and limited antireflux surgery to those patients whose reflux symptoms cannot be adequately controlled with medical therapy. Even in the third millennium, PPIs remain the cornerstone of medical management for gastroesophageal reflux disease (GERD) and its associated complications [1–3]. In recent decades, it has become increasingly evident that several clinical needs in the treatment of acid-related conditions remain unmet by the currently available delayed-release PPI formulations [4–7]. Evidence from clinical trials and real-world practice indicates that sustained acid suppression may confer additional therapeutic benefits [8,9]. Consequently, considerable efforts have been directed toward the development of novel therapies – including long-acting PPIs, innovative formulations, and fixed-dose combinations of H2RAs and PPIs – designed to deliver meaningful advances over current treatment options [9,10]. Potassium-competitive acid blockers: a breakthrough in acid suppression therapy An innovative development in acid suppression therapy has been the introduction of H+, K+-ATPase inhibitors, known as potassium-competitive acid blockers (P-CABs) [11,12]. These compounds act by…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 468 participants or records.
Read the paper
Related studies
- The impact of the COVID-19 epidemic on mental health of undergraduate students in New Jersey, cross-sectional study
- Household Secondary Attack Rate of COVID-19 and Associated Determinants in Guangzhou, China: A Retrospective Cohort Study
- Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study
- Lifetime risk of atrial fibrillation according to optimal, borderline, or elevated levels of risk factors: cohort study based on longitudinal data from the Framingham Heart Study
- Nusinersen in adults with 5q spinal muscular atrophy: a non-interventional, multicentre, observational cohort study
- Population-based rates, timing, and causes of maternal deaths, stillbirths, and neonatal deaths in south Asia and sub-Saharan Africa: a multi-country prospective cohort study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.